Champions Oncology Files 10-Q for Q3 2025
Ticker: CSBR · Form: 10-Q · Filed: Mar 17, 2025 · CIK: 771856
| Field | Detail |
|---|---|
| Company | Champions Oncology, INC. (CSBR) |
| Form Type | 10-Q |
| Filed Date | Mar 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-filing, biotechnology
TL;DR
Champions Oncology (CSBR) filed its Q3 2025 10-Q. Business as usual in Baltimore.
AI Summary
Champions Oncology, Inc. filed its 10-Q for the period ending January 31, 2025. The company, previously known as Champions Biotechnology, Inc., is in the biological products sector. Its fiscal year ends on April 30th, and its principal business address is in Baltimore, MD.
Why It Matters
This filing provides investors with an update on Champions Oncology's financial performance and operational status for the third quarter of their fiscal year.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and business information.
Key Players & Entities
- CHAMPIONS ONCOLOGY, INC. (company) — Filer
- CHAMPIONS BIOTECHNOLOGY, INC. (company) — Former Company Name
- BALTIMORE, MD (location) — Business Address
- 20250131 (date) — Period of Report
- 20250317 (date) — Filing Date
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is January 31, 2025.
When was this 10-Q filed with the SEC?
The filing date was March 17, 2025.
What is the company's Central Index Key (CIK)?
The company's CIK is 0000771856.
What was the company formerly known as?
The company was formerly known as Champions Biotechnology, Inc. and Champions Sports Inc.
What is the company's fiscal year end?
The company's fiscal year ends on April 30th.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on March 17, 2025 regarding CHAMPIONS ONCOLOGY, INC. (CSBR).